Comparison of incidence of severe outcomes between COVID-19 and influenza in outpatients without risk factors using health insurance claims database
Not Applicable
- Conditions
- SARS-CoV-2 infection and Influenza virus infection
- Registration Number
- JPRN-UMIN000050806
- Lead Sponsor
- Shionogi & Co., Ltd.
- Brief Summary
Adjusted odds ratios from diagnosis for each severe events (hospitalization, respiratory and heart rate monitoring, oxygen therapy, ventilator use, intensive care unit admission within 28 days, and death within the following month) were significantly higher for patients with COVID-19 than with FLU.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1670991
Inclusion Criteria
Not provided
Exclusion Criteria
Hospitalized on Day1 Risk factors for aggravation (age, malignant tumor, chronic respiratory disease, chronic kidney disease, diabetes, hypertensive disease, dyslipidemia, cardiovascular disease, cerebrovascular disease) disease, morbid obesity, immunosuppressive status, AIDS/HIV)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hospitalization within 4 weeks after consultation, oxygen inhalation, respiratory rate monitoring, ventilator, ICU admission, presence or absence of death within the next month
- Secondary Outcome Measures
Name Time Method